CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Hansson, Oskar, Seibyl, John, Stomrud, Erik, Zetterberg, Henrik, Trojanowski, John Q., Bittner, Tobias, Lifke, Valeria, Corradini, Veronika +9 more·2018·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2018.01.010

Cited by (809)

Items 201–300 of 809

Brainstem substructures and cognition in prodromal Alzheimer’s disease
Shubir Dutt, Yanrong Li, Mara Mather, Daniel A. Nation, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Brain Imaging and Behavior
Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology
Yan Sun, Wei Xu, Keliang Chen, Xue‐Ning Shen, Lan Tan, Jin‐Tai Yu, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Translational Psychiatry
ADNI Biomarker Core: A review of progress since 2004 and future challenges
Leslie M. J. Shaw, Magdalena Korecka, Edward B. Lee, Katheryn A Q Cousins, Hugo Vanderstichele, Suzanne E. Schindler, Duygu Tosun, Mari L. DeMarco, Magdalena Brylska, Yang Wan et al. · 2024 · Alzheimer s & Dementia
Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity
Jeremy A. Elman, Matthew S. Panizzon, Daniel E. Gustavson, Carol E. Franz, Mark E. Sanderson‐Cimino, Michael J. Lyons, William S. Kremen · 2019 · Biological Psychiatry
Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia
Wei Xu, Feng Wei, Xue‐Ning Shen, Yanlin Bi, Ya‐Hui Ma, Jieqiong Li, Qiang Dong, Lan Tan, Jin‐Tai Yu · 2020 · Biological Psychiatry
Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative
Kelsey R. Thomas, Joel S. Eppig, Alexandra J. Weigand, Emily C. Edmonds, Christina G. Wong, Amy J. Jak, Lisa Delano‐Wood, Douglas R Galasko, David P. Salmon, Steven D. Edland et al. · 2019 · Alzheimer s & Dementia
Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms
Smith, Ruben, Hägerström, Douglas, Pawlik, Daria, Klein, Gregory, Jögi, Jonas, Ohlsson, Tomas, Stomrud, Erik, Hansson, Oskar · 2023 · JAMA Neurology
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort
Yian Gu, Lawrence S. Honig, Min Suk Kang, Aanya Bahl, Danurys L. Sanchez, Dolly Reyes‐Dumeyer, Jennifer Jaie Manly, Jeffrey L. Dage, Rafael Lantigua, Adam M. Brickman et al. · 2024 · Alzheimer s & Dementia
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research
Andrei Bieger, Wagner Scheeren Brum, Wyllians Vendramini Borelli, Joseph Therriault, Marco Antônio De Bastiani, Amanda Gressler Moreira, Andréa Lessa Benedet, João Pedro Ferrari‐Souza, Jaderson Costa da Costa, Diogo Onofre Souza et al. · 2024 · Neurology
Orexin and Alzheimer’s Disease: A New Perspective
Yoo Hyun Um, Hyun Kook Lim · 2020 · Psychiatry Investigation
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease
F. Rohden, P. Ferreira, B. Bellaver, J. P. Ferrari-Souza, C. Aguzzoli, Carolina Soares, Sarah Abbas, Hussein Zalzale, G. Povala, F. Lussier et al. · 2025 · Nature Communications
β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly
Anna L. Svenningsson, Erik Stomrud, Philip S. Insel, Niklas Mattsson, Sebastian Palmqvist, Oskar Hansson · 2019 · Scientific Reports
Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease among a Cognitively Healthy Population-Based Cohort
Emma Casey, Zhenjiang Li, Donghai Liang, Stefanie Ebelt, Allan I. Levey, James J. Lah, Thomas S. Wingo, Anke Hüls · 2024 · Environmental Health Perspectives
Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline
Guoyu Lan, Anqi Li, Zhen Liu, Shaohua Ma, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Alzheimer s & Dementia
Freestanding Nanofiber‐Assembled Aptasensor for Precisely and Ultrafast Electrochemical Detection of Alzheimer's Disease Biomarkers
Hui Liu, Xueli Yuan, Tao Liu, Wei Zhang, Heng Dong, Zhenyu Chu · 2024 · Advanced Healthcare Materials
The gamma rhythm as a guardian of brain health
Ana-Maria Ichim, Harald Bârzan, Vasile Vlad Moca, Adriana Nagy-Dăbâcan, Andrei Ciuparu, Adela Hapca, Koen Vervaeke, Raul Cristian Muresan · 2024 · eLife
Long-Term Blood Pressure Variability Across the Clinical and Biomarker Spectrum of Alzheimer’s Disease
Isabel J. Sible, Alzheimer’s Disease Neuroimaging Initiative, Daniel A. Nation · 2020 · Journal of Alzheimer s Disease
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease
Paula Daunt, Clive G. Ballard, Byron Creese, Greg Davidson, John Hardy, Olusegun Oshota, Richard J. Pither, Alex M. Gibson · 2021 · The Journal of Prevention of Alzheimer s Disease
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
Natalia S. Ogonowski, Stefanny Salcidua, Tomás León, Nayaret Chamorro-Veloso, Cristian Valls, Constanza Avalos, Alejandro Bisquertt, Miguel E. Rentería, Paulina Orellana, Claudia A. Duran-Aniotz · 2022 · Frontiers in Aging Neuroscience
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer’s disease pathophysiology in cognitively unimpaired older adults
Douglas Teixeira Leffa, João Pedro Ferrari‐Souza, Bruna Bellaver, Cécile Tissot, Pâmela C.L. Ferreira, Wagner Scheeren Brum, Arthur Caye, Jodie Lord, Petroula Proitsi, Thaís Martins‐Silva et al. · 2022 · Molecular Psychiatry
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Blennow, Kaj, Stomrud, Erik, Zetterberg, Henrik, Borlinghaus, Niels, Corradini, Veronika, Manuilova, Ekaterina, Müller-Hübner, Laura, Quevenco, Frances-Catherine, Rutz, Sandra, Hansson, Oskar · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia
Yue Qin Cai, Dai Shi, Guoyu Lan, Linting Chen, Yanni Jiang, Liemin Zhou, Tengfei Guo, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Neurology
AD biomarker discovery in CSF and in alternative matrices
Giulia Maria Sancesario, Sergio Bernardini · 2019 · Clinical Biochemistry
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease
Lucia Batzu, Eric Westman, Joana B. Pereira · 2019 · Neurobiology of Aging
Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum
Gemma Salvadó, Marta Milà‐Alomà, Mahnaz Shekari, Carolina Minguillón, Karine Fauria, Aida Niñerola‐Baizán, Andrés Perissinotti, Gwendlyn Kollmorgen, Christopher J. Buckley, Gill Farrar et al. · 2021 · Alzheimer s & Dementia
A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease
Marianna Inglese, Neva Patel, Kristofer Linton‐Reid, Flavia Loreto, Zarni Win, Richard J. Perry, Christopher James Carswell, Matthew Grech‐Sollars, William Richard Crum, Haonan Lu et al. · 2022 · Communications Medicine
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Matej Perovnik, Petra Tomše, Jan Jamšek, Andreja Emeršič, Chris C. Tang, David Eidelberg, Maja Trošt · 2022 · Scientific Reports
No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study
Guri Hagberg, Hege Ihle‐Hansen, Brynjar Fure, Bente Thommessen, Håkon Ihle‐Hansen, Anne Rita Øksengård, Mona Kristiansen Beyer, Torgeir Bruun Wyller, Ebba Gløersen Müller, Sarah Tamsin Pendlebury et al. · 2020 · BMC Neurology
Blood pressure variability and medial temporal atrophy in apolipoprotein ϵ4 carriers
Isabel J. Sible, Daniel A. Nation, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Brain Imaging and Behavior
Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials
Mark E. Sanderson‐Cimino, Jeremy A. Elman, Xin Ming Tu, Alden L. Gross, Matthew S. Panizzon, Daniel E. Gustavson, Mark William Bondi, Emily C. Edmonds, Graham M.L. Eglit, Joel S. Eppig et al. · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
Lih‐Fen Lue, Yu‐Min Kuo, Marwan Noel Sabbagh · 2019 · Neurology and Therapy
Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's disease
Annika Hanert, Robby Schönfeld, Frederik D. Weber, Alexander Nowak, Juliane Döhring, Sarah Philippen, Oliver Granert, Andrea Burgalossi, Jan Born A, Daniela Berg et al. · 2023 · Neurobiology of Disease
Associations between misfolded alpha‐synuclein aggregates and Alzheimer's disease pathology in vivo
Alexa Pichet Binette, Angela Mammana, Laura E.M. Wisse, Marcello Rossi, Olof T. Strandberg, Ruben A Smith, Niklas Mattsson, Shorena Janelidze, Sebastian Palmqvist, ADNI et al. · 2024 · Alzheimer s & Dementia
Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation
Stavros Skouras, Jordi Torner, Patrik U. Andersson, Yury Koush, Carles Falcón, Carolina Minguillón, Karine Fauria, Francesc Alpiste, Kaj Blenow, Henrik Zetterberg et al. · 2020 · Brain
Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans
Sohee Moon, Sujin Kim, Sakulrat Mankhong, Seong Hye Choi, Manu Leen Jef Vandijck, Vesna Kostanjevečki, Jee Hyang Jeong, Soo Jin Yoon, Kyung Won Park, Eun Joo Kim et al. · 2021 · Alzheimer s Research & Therapy
Cortical microstructural associations with CSF amyloid and pTau
Talia M. Nir, Julio E. Villalón‐Reina, Lauren E. Salminen, Elizabeth Haddad, Hong Zheng, Sophia I. Thomopoulos, Clifford R. Jack, Michael Walter Weiner, Paul M. Thompson, Neda Jahanshad et al. · 2023 · Molecular Psychiatry
The early diagnosis of Alzheimer's disease: Blood‐based panel biomarker discovery by proteomics and metabolomics
Yun Dong, Xun Song, Xiao Wang, Shaoxiang Wang, Zhendan He · 2024 · CNS Neuroscience & Therapeutics
Ultrasensitive SERS nanoprobe-based multiplexed digital sensing platform for the simultaneous quantification of Alzheimer's disease biomarkers
Jae-Eul Shim, Young Jun Kim, Eunil Hahm, Jong‐Ho Choe, Ahruem Baek, Ryeong Myeong Kim, Eun‐Ah You · 2025 · Biosensors and Bioelectronics
Association of choroid plexus volume with white matter microstructure, glymphatic function, and peripheral systemic inflammation in Alzheimer’s disease
Huwei Xia, Yijia Feng, Han Zhu, Danlu Yang, Chaoqun Wang, Zhipeng Wang, Hanyuan Zhang, Wenhao Pan, Yifan Zhao, Alzheimer’s Disease Neuroimaging Initiative et al. · 2025 · Translational Psychiatry
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
A. Chincarini, Enrico Peira, Silvia Daniela Morbelli, Matteo Pardini, Matteo Bauckneht, Javier Arbizu, Miguel S. Castelo-Branco, K. A. Büsing, Alexandre de Mendonça, Mira Didic et al. · 2019 · NeuroImage Clinical
Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease
Zhibo Wang, Ya‐Hui Ma, Yan Sun, Lan Tan, Hui-Fu Wang, Jin‐Tai Yu, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Journal of Neuroinflammation
Associations of Blood and Cerebrospinal Fluid Aβ and tau Levels with Renal Function
Hao‐Lun Sun, Xiu‐Qing Yao, Lei Li, Wang‐Sheng Jin, Yudi Bai, Gui‐Hua Zeng, An‐Yu Shi, Jun Liang, Li Zhu, Yu-Hui Liu et al. · 2023 · Molecular Neurobiology
Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease
Shaozhen Yan, Chaojie Zheng, Manish D. Paranjpe, Jian Li, Tammie L.S. Benzinger, Jie Lu, Yun Zhou · 2020 · Theranostics
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease
Harald Juergen Hampel, Andrea Vergallo, Mohammad Afshar, Leyla Akman-Anderson, Joaquı́n Arenas, Norbert Benda, Richard Batrla, Karl Broich, Filippo Caraci, A. Claudio Cuello et al. · 2019 · Dialogues in Clinical Neuroscience
Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years
Keith A. Josephs, Stephen D. Weigand, Jennifer Louise Whitwell · 2022 · Neurology
The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer’s Disease
Fan, Dong-Yu, Sun, Hao-Lun, Sun, Pu-Yang, Jian, Jie-Ming, Li, Wei-Wei, Shen, Ying-Ying, Zeng, Fan, Wang, Yan-Jiang, Bu, Xian-Le · 2021 · Frontiers in Neuroscience
LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Lana M. Chahine, David-Erick Lafontant, Seung Ho Choi, Hirotaka Iwaki, Cornelis Blauwendraat, Andrew Singleton, Michael C. Brumm, Roy N. Alcalay, Kalpana Merchant, Kelly Nicole Holohan Nudelman et al. · 2025 · Brain Communications
Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting
Na‐Yeon Jung, Eun Soo Kim, Hyang-Sook Kim, Sumin Jeon, Myung Jun Lee, Kyoungjune Pak, Jae‐Hyeok Lee, Young Min Lee, Kangyoon Lee, Jin‐Hong Shin et al. · 2020 · Journal of Alzheimer s Disease
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
Karine Provost, Leonardo Iaccarino, David N. Soleimani‐Meigooni, Suzanne L. Baker, Lauren Edwards, Udo Eichenlaub, Oskar Hansson, William J. Jagust, Mustafa Janabi, Renaud La Joie et al. · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
Katheryn A Q Cousins, David John Irwin, Thomas Francis Tropea, Emma Rhodes, Jeffrey S. Phillips, Alice S. Chen‐Plotkin, Michael C. Brumm, Christopher S. Coffey, Ju‐Hee Kang, Tanya Simuni et al. · 2024 · Neurology
A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies
Daniela Perani, Leonardo Iaccarino, Adriaan A. Lammertsma, Albert D. Windhorst, Paul Edison, Ronald Boellaard, Oskar Hansson, Agneta K. Nordberg, Andreas Hans Jacobs, IMBI Project · 2019 · Alzheimer s & Dementia
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC–MS/MS Reference Method
Magdalena Korecka, Michal Figurski, Susan M. Landau, Magdalena Brylska, Jacob Alexander, Kaj Blennow, Henrik Zetterberg, William Jagust, John Q. Trojanowski, Leslie M. J. Shaw et al. · 2020 · Clinical Chemistry
Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
K. Thomas, K. Bangen, E. C. Edmonds, Alexandra J. Weigand, Kayla S. Walker, M. Bondi, D. Galasko · 2021 · Alzheimer's & Dementia
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
Matthew D. Howe, Karysa J. Britton, Hannah E. Joyce, William E. Menard, Sheina Emrani, Zachary J. Kunicki, Melanie A. Faust, Brittany C. Dawson, Meghan C. Riddle, Edward D. Huey et al. · 2024 · Alzheimer s Research & Therapy
Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
Wei Xu, Alzheimer’s Disease Neuroimaging Initiative, Bing‐Jie Su, Xue‐Ning Shen, Yanlin Bi, Chen‐Chen Tan, Jieqiong Li, Xi‐Peng Cao, Qiang Dong, Lan Tan et al. · 2020 · Aging
Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study
Ya‐Hui Ma, Jiahuan Wu, Wei Xu, Xue‐Ning Shen, Hui-Fu Wang, Xiao‐He Hou, Xi‐Peng Cao, Yanlin Bi, Qiang Dong, Lei Feng et al. · 2020 · Journal of Alzheimer s Disease
On‐line coupling pressurised liquid extraction with two‐dimensional counter current chromatography for isolation of natural acetylcholinesterase inhibitors from Astragalus membranaceus
Sainan Li, Chunming Liu, Yuchi Zhang, Rong Tsao · 2020 · Phytochemical Analysis
Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults
Katherine J. Bangen, Alzheimer’s Disease Neuroimaging Initiative, Kelsey R. Thomas, Danielle L. Sanchez, Emily C. Edmonds, Alexandra J. Weigand, Lisa Delano‐Wood, Mark William Bondi · 2021 · Journal of Alzheimer s Disease
Tau pathology mediates age effects on medial temporal lobe structure
Laura E.M. Wisse, Long Xie, Sandhitsu R. Das, Robin de Florès, Oskar Hansson, Mohamad Habes, Jimit J. Doshi, Christos A. Davatzikos, Paul A. Yushkevich, David A. Wolk · 2021 · Neurobiology of Aging
Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
Stephanie R. Oatman, Joseph S. Reddy, Zachary Quicksall, Minerva M. Carrasquillo, Xue Wang, Chia‐Chen Liu, Yu Yamazaki, Thuy Nguyen, Kimberly G. Malphrus, Michael G. Heckman et al. · 2023 · Molecular Neurodegeneration
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
Xianfeng Yu, Kai Shao, Ke Wan, Taoran Li, Yuxia Li, Xiaoqun Zhu, Ying Han · 2023 · Chinese Medical Journal
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the AppNL−F/NL−F knock-in mouse model of Alzheimer’s disease
Emelie Andersson, Nina Schultz, Takashi Saito, Takaomi C. Saido, Kaj Blennow, Gunnar K. Gouras, Henrik Zetterberg, Oskar Hansson · 2023 · Alzheimer s Research & Therapy
Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework
Xi Xiong, Haijun He, Qianqian Ye, Shuangjie Qian, Shuoting Zhou, Feifei Feng, Evandro Fei Fang, Chenglong Xie · 2023 · CNS Neuroscience & Therapeutics
Risk of cognitive decline progression is associated to increased blood‐brain‐barrier permeability: A longitudinal study in a memory unit clinical cohort
Albert Puig‐Pijoan, Joan Jiménez-Baladó, Aida Fernández‐Lebrero, Greta García‐Escobar, Irene Navalpotro‐Gómez, José Contador, Rosa María Manero-Borràs, Víctor Puente, Antoni Suárez‐Pérez, Francisco J. Muñoz et al. · 2023 · Alzheimer s & Dementia
Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals
Firoza Zubeida Lussier, Andréa Lessa Benedet, Joseph Therriault, Tharick Ali Pascoal, Cécile Tissot, Mira Chamoun, Sulantha Sanjeewa Mathotaarachchi, Mélissa Savard, Nicholas James Ashton, Thomas K. Karikari et al. · 2021 · Brain Communications
Circulating biomarkers of inflammaging and Alzheimer’s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination?
Angela Marie Abbatecola, Angelica Giuliani, Leonardo Biscetti, Lucia Scisciola, Petronilla Battista, Michelangela Barbieri, Jacopo Sabbatinelli, Fabiola Olivieri · 2024 · Ageing Research Reviews
Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory
Alexis Moscoso, Jesús Silva‐Rodríguez, José Manuel Aldrey, Julia Cortés, Anxo Fernández‐Ferreiro, Noemí Gómez‐Lado, Á. Ruibal, Pablo Aguiar · 2019 · Neurobiology of Aging
The power of super-resolution microscopy in modern biomedical science
Nan Sun, Yi Jia, Shiwei Bai, Qi Li, Luru Dai, Junbai Li · 2023 · Advances in Colloid and Interface Science
A Sensitive and Cost-Effective Chemiluminescence ELISA for Measurement of Amyloid-β 1-42 Peptide in Human Plasma
Pankaj D Mehta, Bruce A. Patrick, David L. Miller, Patricia Katherine Coyle, Thomas Wısnıewskı · 2020 · Journal of Alzheimer s Disease
Episodic Memory–Related Imaging Features as Valuable Biomarkers for the Diagnosis of Alzheimer’s Disease: A Multicenter Study Based on Machine Learning
Yachen Shi, Zan Wang, Pindong Chen, Piaoyue Cheng, Kun Zhao, Hongxing Zhang, Hao Shu, Lihua Gu, Lijuan Gao, Qīng Wáng et al. · 2020 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
Investigating hypotheses of neurodegeneration by learning dynamical systems of protein propagation in the brain
Sara Garbarino, Marco Lorenzi · 2021 · NeuroImage
Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
Yi-He Chen, Rong-Rong Lin, Hui-Feng Huang, Yan‐Yan Xue, Qing‐Qing Tao · 2022 · Frontiers in Aging Neuroscience
Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk
Yuetiva K. Deming, Eva Vasiljevic, Autumn Rose Morrow, Jiacheng Miao, Carol Van Hulle, Erin McMullen Jonaitis, Yue Ma, Vanessa M Whitenack, Gwendlyn Kollmorgen, Norbert Wild et al. · 2023 · Alzheimer s & Dementia
The clinical importance of suspected non-Alzheimer disease pathophysiology
Stephanie J. B. Vos, Aurore Delvenne, Clifford R. Jack, Dietmar Rudolf Thal, Pieter Jelle Visser · 2024 · Nature Reviews Neurology
MRI-Based Screening of Preclinical Alzheimer’s Disease for Prevention Clinical Trials
Adrià Casamitjana, Paula Petrone, Alan Tucholka, Carles Falcón, Stavros Skouras, José Luís Molinuevo, Verónica Vilaplana, Juan Domingo Gispert, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Journal of Alzheimer s Disease
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly
Jordi Pegueroles, Adriana Pané, Eduard Vilaplana, Víctor Montal, Alexandre Bejanin, Laura Videla, María Carmona‐Iragui, Isabel Barroeta, Ainitze Ibarzábal, Anna Casajoana et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice
Leslie M. J. Shaw, Magdalena Korecka, Michal Figurski, Jon B. Toledo, David John Irwin, Ju‐Hee Kang, John Q. Trojanowski · 2019 · The Journal of Applied Laboratory Medicine
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
Freyja Aichholzer, Hans‐Wolfgang Klafki, Isabella Ogorek, Jonathan S. Vogelgsang, Jens Wiltfang, Norbert Scherbaum, Sascha Weggen, Oliver Wirths · 2021 · Alzheimer s Research & Therapy
Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline
Wiesje Pelkmans, Eleonora M. Vromen, Ellen Dicks, Philip Scheltens, Charlotte Elisabeth Teunissen, Frederik Barkhof, Wiesje M. van der Flier, Betty Marije Tijms, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
Association between lower body temperature and increased tau pathology in cognitively normal older adults
Esther Blessing, Ankit Parekh, Rebecca A. Betensky, James S. Babb, Natalie Saba, Ludovic Debure, Andrew W. Varga, Indu A. Ayappa, David M. Rapoport, Tracy Butler et al. · 2022 · Neurobiology of Disease
The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
Martin Tolar, John A. Hey, Aidan Power, Susan R. Abushakra · 2024 · International Journal of Molecular Sciences
Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer’s disease diagnosis and differential diagnosis
Zhen Guo, Chen Tian, Yang Shi, Xueru Song, Wei Yin, Qing‐Qing Tao, Jie Liu, Guo-Ping Peng, Zhi‐Ying Wu, Yan‐Jiang Wang et al. · 2024 · Acta Neuropathologica Communications
Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer’s disease progression
Neda Shafiee, Vladimir Fonov, Mahsa Dadar, R. Nathan Spreng, D. Louis Collins · 2024 · Neurobiology of Aging
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
for the IMI-EPAD collaborators, Lisa Vermunt, Graciela Muniz Terrera, Lea ter Meulen, Colin Veal, Kaj Blennow, Archie I Campbell, Isabelle Carrié, Julien Delrieu, Karine Fauria et al. · 2020 · Alzheimer s Research & Therapy
Comparative Analysis of Different Definitions of Amyloid-β Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer
Marta Milà‐Alomà, Gemma Salvadó, Mahnaz Shekari, Oriol Grau‐Rivera, Aleix Sala‐Vila, Gonzalo Sánchez‐Benavides, Eider M. Arenaza‐Urquijo, José María Gónzalez‐de‐Echávarri, Maryline Simon, Gwendlyn Kollmorgen et al. · 2021 · The Journal of Prevention of Alzheimer s Disease
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load
Antoine Leuzy, Johan Lilja, Christopher J. Buckley, Rik Ossenkoppele, Sebastian Palmqvist, Mark R Battle, Gill Farrar, Dietmar Rudolf Thal, Shorena Janelidze, Erik Stomrud et al. · 2020 · Neurology
Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods
Alzheimer’s Disease Neuroimaging Initiative, A Sörensen, Ganna Blazhenets, Florian Schiller, Philipp Tobias Meyer, Lars Frings · 2020 · Alzheimer s Research & Therapy
Establishment of combined diagnostic models of Alzheimer’s disease in a Chinese cohort: the Chongqing Ageing & Dementia Study (CADS)
Dong‐Yu Fan, Jie-Ming Jian, Shan Huang, Weiwei Li, Ying‐Ying Shen, Zhen Wang, Gui‐Hua Zeng, Xu Yi, Wang‐Sheng Jin, Yu-Hui Liu et al. · 2022 · Translational Psychiatry
Characteristics of very late-onset schizophrenia-like psychosis classified with the biomarkers for Alzheimer’s disease: a retrospective cross-sectional study
Yuto Satake, Hideki Kanemoto, Daiki Taomoto, Takashi Suehiro, Fuyuki Koizumi, Shunsuke Sato, Tamiki Wada, Keiko Matsunaga, Eku Shimosegawa, Shiho Gotoh et al. · 2023 · International Psychogeriatrics
Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's disease and healthy aging
Benoît Sauty, Stanley Durrleman · 2023 · Frontiers in Neurology
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
Guoqiao Wang, Chengjie Xiong, Eric McDade, Jason J. Hassenstab, Andrew J. Aschenbrenner, Anne M. Fagan, Tammie L.S. Benzinger, Brian Andrew Gordon, John C. Morris, Yan Li et al. · 2018 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Fluid biomarkers for neurodegenerative diseases: a comprehensive update
Martina Valletta, Nils Briel, Idil Yuksekel, Michelle C. Barboure, A. R. Coward, Julie F. H. De Houwer, Ayesha Fawad, Alberto González-Mayoral, Gianmarco Iaccarino, Francisco Martínez‐Dubarbie et al. · 2025 · Alzheimer s Research & Therapy
Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy
Mikio Shoji · 2019 · Advances in experimental medicine and biology
Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer’s Disease
Fatemah Sakr, Alzheimer’s Disease Neuroimaging Initiative, Martin Dyrba, Anja Bräuer, Stefan Teipel · 2021 · Journal of Alzheimer s Disease
Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism
Young‐gun Lee, Seun Jeon, Min-Cheol Park, Sung Woo Kang, So Hoon Yoon, Kyoungwon Baik, Phil Hyu Lee, Young H. Sohn, Byoung Seok Ye, the Alzheimer's Disease Neuroimaging Initiative · 2022 · Annals of Neurology
Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
Yuanyuan Lu · 2022 · Frontiers in Aging Neuroscience
The CORCOBIA study: Cut-off points of Alzheimer’s disease CSF biomarkers in a clinical cohort
Albert Puig‐Pijoan, Greta García‐Escobar, Aida Fernández‐Lebrero, Rosa María Manero-Borràs, Gonzalo Sánchez‐Benavides, Irene Navalpotro‐Gómez, Diego Cascales‐Lahoz, Marc Suárez‐Calvet, Oriol Grau‐Rivera, Anunciación Boltes et al. · 2022 · Neurología (English Edition)
Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy
Zhibo Wang, Lan Tan, Hui-Fu Wang, Shi‐Dong Chen, Yan Fu, Pei‐Yang Gao, Ya‐Hui Ma, Yu Guo, Jia‐Hui Hou, Dandan Zhang et al. · 2023 · Alzheimer s & Dementia
Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer’s Disease-Related Biomarkers
Nicholas J. Schork, Jeremy A. Elman, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Journal of Alzheimer s Disease
Optimising Alzheimer's Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
Sandar Aye, Ron L. H. Handels, Bengt G. Winblad, Linus Jönsson · 2024 · The Journal of Prevention of Alzheimer s Disease